Tag: WHO

  • COVID Cases Rise Again – but Don’t Overreact

    Key Points: In today’s Recommendation for Industry, we discuss how COVID cases are rising. Read more below. CDC panel recommends Novavax vaccine as BA.5 gains more ground. On July 19, CDC vaccine advisers unanimously approved recommended the use of the Novavax COVID-19 vaccine for the primary series for people 18 years and older. The CDC…

  • COVID Showing Stable and Declining Global Rates

    Key Points: In today’s Recommendations for Industry, we discuss COVID-19 trends stabilizing and declining. Read more below. The CDC released research done on post-COVID conditions among adult COVID-19 survivors aged 18-64 and younger than 65, here are some results: Another figure shows additional areas of the body that were included in the research conducted. Independent…

  • As COVID Recedes, New Challenges Arise

    Key Points: In today’s Recommendations for Industry, we discuss how COVID-19 has impacted other areas of public health. Read more below. In the U.S., new COVID-19 cases have dropped by 42%; although death rates and hospitalizations remain high (CIDRAP). However, around the world, COVID-19 still persists. In fact, in Hong Kong, daily cases have now…

  • COVID Declining; Continuing to Impart Lessons for Infectious Disease Control

    Key Points: In today’s Recommendations for Industry, we discuss the continued decline of COVID and the lessons it continues to impart for infectious disease (and “next pandemic”) control. Read more below. The future of the pandemic is looking clearer as we learn more about infection (NPR). New studies are providing an optimistic picture about immunity…

  • TAG Holds Guarded Optimism for the Ebbing of Omicron

    Key Points: In today’s Recommendations for Industry, we discuss our guarded optimism for the ebbing of Omicron. Read more below. OSHA Withdraws Its Workplace Vaccine Rule. On Tuesday, OSHA announced its withdrawal of the November 5, 2021, ETS issued to “protect unvaccinated employees of large employers (100 or more employees) from the risk of contracting…

  • Are You Prepared for a Twindemic?

    Key Points In today’s Recommendations for Industry, we discuss the possibility of a “twindemic” and how businesses can prepare. Read more below. The Omicron variant is now dominant in the U.S., accounting for 73% of all new COVID-19 cases. However, the Delta variant does continue to spread. In Canada, Quebec “became the latest region to…

  • Delta Wave Continues in U.S.; Be Sure Handwashing is Included in Protective Measures

    Key Points In today’s Recommendations for Industry, we discuss the continuing wave of the Delta variant and the importance of including handwashing in protective measures. Read more below. The U.S. Senate has approved and passed the bill to overturn Biden’s vaccine mandate (Reuters). The FDA has updated its COVID-19 Tests page with updates on different…

  • Omicron Detected; Biden to Announce New COVID Protections

    Key Points In today’s Recommendations for Industry, we discuss the detection of Omicron in the U.S. and the White House announcement of new COVID protections. Read more below. The first case of the omicron variant has been identified in the U.S. in San Francisco, CA. CNBC also details a map of where the omicron variant…

  • Exclusive TAG Update: Yes, Omicron Has Spread, but NOT a Cause for Panic

    Exclusive TAG Update: Yes, Omicron Has Spread, but NOT a Cause for Panic The omicron variant of COVID-19, which was first identified in South Africa, has been detected in multiple countries, including many in Europe as well as Israel, Hong Kong, and Canada – and we can reasonably assume that it is in the U.S.…

  • Triad of Trends Compels Double-Down on Symptom Monitoring

    Key Points In today’s Recommendations for Industry, we emphasize the importance of monitoring symptoms as the rise of COVID-19, flu, or other respiratory illnesses begins into the winter months. Read more below. The FDA has expanded the eligibility for COVID-19 vaccine boosters, recommending and “authorizing use of a single booster dose for all individuals 18…